» Articles » PMID: 34158498

Artificially Engineered Antiferromagnetic Nanoprobes for Ultra-sensitive Histopathological Level Magnetic Resonance Imaging

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Jun 23
PMID 34158498
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Histopathological level imaging in a non-invasive manner is important for clinical diagnosis, which has been a tremendous challenge for current imaging modalities. Recent development of ultra-high-field (UHF) magnetic resonance imaging (MRI) represents a large step toward this goal. Nevertheless, there is a lack of proper contrast agents that can provide superior imaging sensitivity at UHF for disease detection, because conventional contrast agents generally induce T2 decaying effects that are too strong and thus limit the imaging performance. Herein, by rationally engineering the size, spin alignment, and magnetic moment of the nanoparticles, we develop an UHF MRI-tailored ultra-sensitive antiferromagnetic nanoparticle probe (AFNP), which possesses exceptionally small magnetisation to minimize T2 decaying effect. Under the applied magnetic field of 9 T with mice dedicated hardware, the nanoprobe exhibits the ultralow r/r value (~1.93), enabling the sensitive detection of microscopic primary tumours (<0.60 mm) and micrometastases (down to 0.20 mm) in mice. The sensitivity and accuracy of AFNP-enhanced UHF MRI are comparable to those of the histopathological examination, enabling the development of non-invasive visualization of previously undetectable biological entities critical to medical diagnosis and therapy.

Citing Articles

Taprenepag restores maternal-fetal interface homeostasis for the treatment of neurodevelopmental disorders.

Wang K, Zhang S, Wang Y, Wu X, Wen L, Meng T J Neuroinflammation. 2024; 21(1):307.

PMID: 39609821 PMC: 11603931. DOI: 10.1186/s12974-024-03300-7.


Responsive probes for in vivo magnetic resonance imaging of nitric oxide.

Lu C, Liao S, Chen B, Xu L, Wu N, Lu D Nat Mater. 2024; 24(1):133-142.

PMID: 39587281 DOI: 10.1038/s41563-024-02054-0.


Counting cells in motion by quantitative real-time magnetic particle imaging.

Remmo A, Kosch O, Kampen L, Ludwig A, Wiekhorst F, Lowa N Sci Rep. 2024; 14(1):4253.

PMID: 38378785 PMC: 10879211. DOI: 10.1038/s41598-024-54784-5.


Stimuli-responsive crosslinked nanomedicine for cancer treatment.

Xue X, Qu H, Li Y Exploration (Beijing). 2023; 2(6):20210134.

PMID: 37324805 PMC: 10190936. DOI: 10.1002/EXP.20210134.


PDGFB-targeted functional MRI nanoswitch for activatable T-T dual-modal ultra-sensitive diagnosis of cancer.

Zhang Y, Liu L, Li W, Zhang C, Song T, Wang P J Nanobiotechnology. 2023; 21(1):9.

PMID: 36609374 PMC: 9824934. DOI: 10.1186/s12951-023-01769-7.


References
1.
Lee J, Gordon A, Kim H, Park W, Cho S, Lee B . Targeted multimodal nano-reporters for pre-procedural MRI and intra-operative image-guidance. Biomaterials. 2016; 109:69-77. PMC: 5055467. DOI: 10.1016/j.biomaterials.2016.09.013. View

2.
Steeg P . Targeting metastasis. Nat Rev Cancer. 2016; 16(4):201-18. PMC: 7055530. DOI: 10.1038/nrc.2016.25. View

3.
. Histopathology is ripe for automation. Nat Biomed Eng. 2019; 1(12):925. DOI: 10.1038/s41551-017-0179-5. View

4.
Zhang W, Liu L, Chen H, Hu K, Delahunty I, Gao S . Surface impact on nanoparticle-based magnetic resonance imaging contrast agents. Theranostics. 2018; 8(9):2521-2548. PMC: 5928907. DOI: 10.7150/thno.23789. View

5.
Liu C, Zhao J, Tian F, Cai L, Zhang W, Feng Q . Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers. Nat Biomed Eng. 2019; 3(3):183-193. DOI: 10.1038/s41551-018-0343-6. View